lupus

Darmstadt, Germany | April 30, 2026 Merck has announced the first patient dosing in its global Phase 3 ELOWEN...

MONTEVIDEO, Uruguay & NEW YORK, United States, April 7, 2026 Resolve Therapeutics and the Institut Pasteur de Montevideo announced...

Dateline — CARLSBAD, Calif., November 11, 2025:Exagen Inc. (Nasdaq: XGN), a leader in autoimmune diagnostics, has announced its participation...